Abstract:Introduction Klebsiella pneumonia is one of the most prevalent bacteria that cause nosocomial infections, particularly in critically ill patients in the intensive care unit (ICU). Multi-drug-resistant Klebsiella pneumoniae (MDRKP) has become an urgent risk to public health as its prevalence has sharply surged around the globe in recent decades. Therefore, this research was conducted to evaluate shifts over a four-year period in drug susceptibility patterns among Klebsiella pneumoniae isolates from mechanically ventilated intensive care unit patients. Materials and methods This is a retrospective observational study conducted in a tertiary care multi-specialty hospital and teaching institute in North India and was approved by the institutional ethics committee. The research comprised Klebsiella pneumoniae isolates from endotracheal aspirates (ETA) of patients on mechanical ventilation admitted to the general intensive care unit (ICU) of our tertiary care facility. The data from January to June 2018 and January to June 2022 were collected. According to the antimicrobial resistance profile of the strains, they were categorized as susceptible, resistant to one or two antimicrobial categories, multidrug-resistant (MDR), extensively drug-resistant (XDR), or pan-drug-resistant (PDR). The criteria for MDR, XDR, and PDR were proposed by the European Centre for Disease Prevention and Control (ECDC). IBM Statistical Package for the Social Sciences (SPSS) for Windows, Version 24.0, Armonk, NY, IBM Corp., was used for data input and analysis. Results A total of 82 cases of Klebsiella pneumonia were included in the study. Of these 82 isolates, 40 were isolated over a period of six months from January to June 2018, and the remaining 42 were isolated from January to June 2022. Among the 2018 group, five strains (12.5%) were classified as susceptible, three (7.5%) as resistant, seven (17.5%) as MDR, and 25 (62.5%) as XDR. The highest percentages of antimicrobial resistance in the 2018 group were observed with amoxicillin/clavulanic acid (90%), ciprofloxacin (100%), piperacillin/tazobactam (92.5%), and cefoperazone/sulbactam (95%). In comparison, the 2022 group showed no strain as susceptible; nine strains (21.4%) were classified as resistant; three strains (7%) as MDR; and 30 strains (93%) were classified as XDR. There was a significant increase in resistance to amoxicillin, from 10% in 2018 to nil in 2022. Overall, the rate of resistant Klebsiella pneumonia (K. pneumonia) increased from 7.5% (3/40) in 2018 to 21.4% (9/42) in 2022, while XDR Klebsiella pneumonia among the mechanically ventilated ICU patients significantly increased from 62.5% (25/40) in 2018 to 71% (30/42) in 2022. Conclusion K. pneumoniae antibiotic resistance is a real threat in Asia and requires close monitoring to be controlled. More careful attempts should be made to create a new generation of antimicrobials since the prevalence of resistance to existing medications is rising. Antibiotic resistance should be monitored and reported by healthcare institutions regularly.

Hospital-acquired infections in the neonatal intensive care unit-Klebsiella pneumoniae

Infections Caused by Carbapenemase-Producing Klebsiella Pneumoniae: Microbiological Characteristics and Risk Factors

Extended-Spectrum Beta-Lactamase-Producing Klebsiella Pneumoniae Infection in A Neonatal Intensive Care Unit

A Retrospective Study Of Risk Factors For Carbapenem-Resistant Klebsiella Pneumoniae Acquisition Among Icu Patients

Clinical Characteristics, Risk Factors, and Outcomes of Patients with Polymicrobial Klebsiella Pneumoniae Bloodstream Infections

Dynamic Colonization of Klebsiella Pneumoniae Isolates in Gastrointestinal Tract of Intensive Care Patients

Klebsiella spp. as Nosocomial Pathogens: Epidemiology, Taxonomy, Typing Methods, and Pathogenicity Factors

Antimicrobial resistance profiles and genome characteristics of Klebsiella isolated from the faeces of neonates in the neonatal intensive care unit

Virulence Factors and Antibiotic Resistance of Klebsiella pneumoniae Strains Isolated From Neonates With Sepsis

Clinical Epidemiology, Risk Factors, and Control Strategies of Klebsiella pneumoniae Infection

[A case of Klebsiella pneumoniae outbreak in a newborn intensive care unit].

The Epidemiology, Virulence and Antimicrobial Resistance of Invasive Klebsiella Pneumoniae at a Children’s Medical Center in Eastern China

Epidemiology and Virulence of Klebsiella pneumoniae

Klebsiella pneumoniae Bacteremia Presenting on a Neonatal Intensive Care Unit during the First Week of Life

Relevance and antimicrobial resistance profile of Klebsiella pneumoniae in neonatal sepsis

Changing Landscape of Antimicrobial Resistance in Neonatal Sepsis: An in silico Analyses of Multidrug Resistance in Klebsiella pneumoniae

The Colonization Of Carbapenem-Resistant Klebsiella Pneumoniae: Epidemiology, Resistance Mechanisms, And Risk Factors In Patients Admitted To Intensive Care Units In China

Detection of virulence factors and antimicrobial susceptibility pattern of clinically significant Klebsiella pneumoniae isolates in a tertiary care hospital

Investigation of Burkholderia cepacia complex bacteremia outbreak in a neonatal intensive care unit: a case series

Changing Trend in the Antibiotic Resistance Pattern of Klebsiella Pneumonia Isolated From Endotracheal Aspirate Samples of ICU Patients of a Tertiary Care Hospital in North India

Multidrug-resistant and carbapenemase-producing critical gram-negative bacteria isolated from the intensive care unit environment in Amhara region, Ethiopia